SOSV

Synplexity is a biotechnology company located in New Castle, Delaware, specializing in mutational scanning and multiplexed gene synthesis through advanced artificial intelligence technology. The company operates a large-scale gene synthesis and proteomics discovery platform that utilizes microdroplets as microreactors. This innovative approach allows for the efficient creation of multiplex gene libraries, which have applications across various sectors, including therapeutics, biomanufacturing, agriculture, and climate systems. Synplexity aims to drive advancements in healthcare and other industries through its cutting-edge genetic technologies.

Kotal is a developer of cloud-native deployment tools focused on managing the lifecycle of blockchain infrastructure. Founded in 2020 and headquartered in Middletown, Delaware, the company offers a platform designed to assist clients in deploying self-managing and self-healing blockchain solutions. Kotal's platform includes features such as open-source tools, protocol agnosticism, key management, and multi-client support, allowing businesses to efficiently handle various aspects of blockchain infrastructure, including deployment, integration, security, logging, and monitoring.

Pregenerate, Inc., founded in 2019 and incorporated in Delaware, specializes in developing innovative organ-on-a-chip technology aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. The company's scalable models utilize human cells, allowing pharmaceutical companies to significantly reduce costs and improve drug success rates. Pregenerate's technology not only enhances the efficiency of research but also facilitates the stratification of patients into targeted treatment subgroups, enabling personalized medicine approaches. By providing these advanced solutions, Pregenerate aims to transform the research landscape and improve treatment outcomes for individuals with arthritis.

AYLIEN is an artificial intelligence company that specializes in natural language processing and text analysis, offering APIs and platforms to help users understand and extract insights from large volumes of human-generated content. Its offerings include information retrieval, machine learning, and image recognition APIs, as well as tools for news intelligence and content analysis that serve developers, data scientists, marketers and academics. The company provides an open platform for building micro applications that convert unstructured or semi-structured data into structured, machine-readable information, and it offers products such as Talk.ee and an educational App Engine to enable automated data collection, categorization and updates on topics of interest. AYLIEN aims to empower enterprises to analyze text and images at scale and to turn diverse data sources into actionable insights.

Pregenerate, Inc., founded in 2019 and incorporated in Delaware, specializes in developing innovative organ-on-a-chip technology aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. The company's scalable models utilize human cells, allowing pharmaceutical companies to significantly reduce costs and improve drug success rates. Pregenerate's technology not only enhances the efficiency of research but also facilitates the stratification of patients into targeted treatment subgroups, enabling personalized medicine approaches. By providing these advanced solutions, Pregenerate aims to transform the research landscape and improve treatment outcomes for individuals with arthritis.

Pregenerate, Inc., founded in 2019 and incorporated in Delaware, specializes in developing innovative organ-on-a-chip technology aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. The company's scalable models utilize human cells, allowing pharmaceutical companies to significantly reduce costs and improve drug success rates. Pregenerate's technology not only enhances the efficiency of research but also facilitates the stratification of patients into targeted treatment subgroups, enabling personalized medicine approaches. By providing these advanced solutions, Pregenerate aims to transform the research landscape and improve treatment outcomes for individuals with arthritis.

AYLIEN is an artificial intelligence company that specializes in natural language processing and text analysis, offering APIs and platforms to help users understand and extract insights from large volumes of human-generated content. Its offerings include information retrieval, machine learning, and image recognition APIs, as well as tools for news intelligence and content analysis that serve developers, data scientists, marketers and academics. The company provides an open platform for building micro applications that convert unstructured or semi-structured data into structured, machine-readable information, and it offers products such as Talk.ee and an educational App Engine to enable automated data collection, categorization and updates on topics of interest. AYLIEN aims to empower enterprises to analyze text and images at scale and to turn diverse data sources into actionable insights.

Bioptamers develops personalized cancer therapies using synthetic aptamers, which are short nucleic acid molecules that selectively bind to cancer cells. This enables targeted delivery of chemotherapy, radiation, and immunotherapy agents, aiming to improve clinical outcomes for cancer patients.

Pregenerate, Inc., founded in 2019 and incorporated in Delaware, specializes in developing innovative organ-on-a-chip technology aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. The company's scalable models utilize human cells, allowing pharmaceutical companies to significantly reduce costs and improve drug success rates. Pregenerate's technology not only enhances the efficiency of research but also facilitates the stratification of patients into targeted treatment subgroups, enabling personalized medicine approaches. By providing these advanced solutions, Pregenerate aims to transform the research landscape and improve treatment outcomes for individuals with arthritis.

AYLIEN is an artificial intelligence company that specializes in natural language processing and text analysis, offering APIs and platforms to help users understand and extract insights from large volumes of human-generated content. Its offerings include information retrieval, machine learning, and image recognition APIs, as well as tools for news intelligence and content analysis that serve developers, data scientists, marketers and academics. The company provides an open platform for building micro applications that convert unstructured or semi-structured data into structured, machine-readable information, and it offers products such as Talk.ee and an educational App Engine to enable automated data collection, categorization and updates on topics of interest. AYLIEN aims to empower enterprises to analyze text and images at scale and to turn diverse data sources into actionable insights.

AYLIEN is an artificial intelligence company that specializes in natural language processing and text analysis, offering APIs and platforms to help users understand and extract insights from large volumes of human-generated content. Its offerings include information retrieval, machine learning, and image recognition APIs, as well as tools for news intelligence and content analysis that serve developers, data scientists, marketers and academics. The company provides an open platform for building micro applications that convert unstructured or semi-structured data into structured, machine-readable information, and it offers products such as Talk.ee and an educational App Engine to enable automated data collection, categorization and updates on topics of interest. AYLIEN aims to empower enterprises to analyze text and images at scale and to turn diverse data sources into actionable insights.

AYLIEN is an artificial intelligence company that specializes in natural language processing and text analysis, offering APIs and platforms to help users understand and extract insights from large volumes of human-generated content. Its offerings include information retrieval, machine learning, and image recognition APIs, as well as tools for news intelligence and content analysis that serve developers, data scientists, marketers and academics. The company provides an open platform for building micro applications that convert unstructured or semi-structured data into structured, machine-readable information, and it offers products such as Talk.ee and an educational App Engine to enable automated data collection, categorization and updates on topics of interest. AYLIEN aims to empower enterprises to analyze text and images at scale and to turn diverse data sources into actionable insights.

AYLIEN is an artificial intelligence company that specializes in natural language processing and text analysis, offering APIs and platforms to help users understand and extract insights from large volumes of human-generated content. Its offerings include information retrieval, machine learning, and image recognition APIs, as well as tools for news intelligence and content analysis that serve developers, data scientists, marketers and academics. The company provides an open platform for building micro applications that convert unstructured or semi-structured data into structured, machine-readable information, and it offers products such as Talk.ee and an educational App Engine to enable automated data collection, categorization and updates on topics of interest. AYLIEN aims to empower enterprises to analyze text and images at scale and to turn diverse data sources into actionable insights.